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Phenotypic profiles for microbial identification are unusual for rare, slow-growing and fastidious 
microorganisms. In the last decade, as a result of the widespread use of PCR and DNA sequencing, 16S 
rRNA sequencing has played a pivotal role in the accurate identification of microorganisms and the 
discovery of novel isolates in microbiology laboratories. The 16S rRNA region is universally distributed 
among microorganisms and is species-specific. Accordingly, the aim of our study was the genotypic 
identification of microorganisms isolated from non-parenteral pharmaceutical formulations. DNA was 
separated from five isolates obtained from the formulations. The target regions of the rRNA genes were 
amplified by PCR and sequenced using suitable primers. The sequence data were analyzed and aligned 
in the order of increasing genetic distance to relevant sequences against a library database to achieve an 
identity match. The DNA sequences of the phylogenetic tree results confirmed the identity of the isolates 
as Bacillus tequilensis, B. subtilis, Staphylococcus haemolyticus and B. amyloliqueficians. It can be 
concluded that 16S rRNA sequence-based identification reduces the time by circumventing biochemical 
tests and also increases specificity and accuracy.
Uniterms Non-parenteral products/microbiological contamination. Microbes/identification/non-parenteral 
products. Phylogenetic analysis/microbial identification. 16S rRNA/use/microbial identification.
Os perfis fenotípicos para identificação microbiana são incomuns para micro-organismos raros, de 
crescimento lento e exigentes. Na última década, em resultado do uso generalizado de PCR e sequenciação 
de DNA, a sequenciação do rRNA 16S tem desempenhado papel crucial na identificação precisa do 
micro-organismo e a descoberta de novos isolados em laboratórios de microbiologia. A região de rRNA 
16S é universalmente distribuída entre micro-organismos e é espécie-específica. A genotipagem foi 
realizada sobre os organismos isolados a partir de formulações farmacêuticas não parenterais. O DNA 
foi separado dos cinco isolados obtidos a partir das formulações. As regiões alvo dos genes de rRNA 
foram amplificados por PCR e sequenciados utilizando os iniciadores adequados. Os dados dos sequência 
foram analisados e alinhados na ordem crescente de distância genética de sequências relevantes contra 
biblioteca de dados para obter a identidade. A sequência de DNA de árvores filogenéticas confirma 
a identidade dos isolados como Bacillus-tequilensis, B. subtilis, Staphylococcus haemolyticus e B. 
amyloliqueficians. Pode-se concluir identificação baseada na sequência do rRNA 16S reduz o tempo 
por evitar testes bioquímicos e também aumenta a especificidade e a precisão. 
Unitermos: Produtos não-parenterais/contaminação microbiana. Micróbios/identificação/produtos não-
parenterais. Análise filogenética/identificação microbiana. 16S rRNA/use/ identificação microbiana.
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INTRODUCTION
Microbiological contamination is a serious problem, 
because it not only results in the spoilage of medicines but 
also causes infections, and hence, several classical culture 
methods have evolved to determine the microbiological 
quality of non-parenteral pharmaceutical products (Jasson 
et al., 2010; Rosa, Medina, Vivar, 1995). These protocols 
are time-consuming and labor-intensive to ensure the 
microbiological quality of non-parenteral products. The 
inevitable time delay associated with incubation often 
determines that microbiological quality assurance data 
are only of retrospective value. Modern pharmaceutical 
production and economic pressures can no longer 
accommodate this delay (Newby, 2000). In the past 
decade, nucleic acid sequencing methods have undergone 
tremendous advances (such as whole-genome sequencing 
as well as the determination of 16S rRNA, 16S-23S 
rRNA, spacer and 23S rRNA sequences), which minimize 
the time needed for identification of microorganisms. 
16S rRNA sequencing analysis is widely used, (Bansal, 
Meyer, 2002) and more useful in phylogenetic analysis 
compared to 16S-23S rRNA sequencing (Song et al., 
2004) and also due to its rapidity, reliability, simplicity 
and reproducibility (Lane et al., 1985; Patel 2001; Easter 
2003). This identification method not only confirms the 
microbial limits suggested in official pharmacopoeias but 
also demonstrates the presence of any other pathogens 
by virtue of its specificity (Rompre et al., 2002; Gee et 
al. 2003; Rhoads et al., 2012). Recent studies and micro 
sequence packages indicate the cost of analysis is low 
(Cook et al., 2003; Hall et al., 2003; Woo et al., 2003). 
16S rRNA sequencing is routinely used in the clinical 
laboratory but rarely used for microbial limits test for non-
parenteral products. Hence, the aim of the present work 
was to evaluate 16S rRNA sequence-based identification 
of microbial contaminants in non-parenteral products.
MATERIAL AND METHODS
(1 )  Sequenc ing  Ki t :  ABI  3100  (App l i ed 
Biosystems) with Big Dye Terminator Kit v.3.1 
(Applied Biosystems) (2) Universal primers: 27F 
( 5 ′ G A G T T T G AT C AT G G C T C A G 3 ′ ) ,  1 4 9 2 R 
(5′GGTTACCTTGTTACGACTT3′) [for PCR] and 
518F (5’CCAGCAGCCGCGGTAATACG3’) and 
800R (5’TACCAGGGTATCTAATCC3’) [for 16S 
rRNA sequencing] were purchased from Macrogen. (3) 
Sequencer: ABI PRISM 3730XL Analyzer (96 capillary 
type) (3) PCR machine: MJ Research PTC-225 Peltier 
Thermal Cycler. All chemicals were purchased from 
Hi-media &Sigma Aldrich Mumbai. The non-parenteral 
products (syrup and tablets) were purchased from retail 
medical shops in TamilNadu. 
Preparation of the sample
For isolation of specific organism present in the 
non parenteral products (Syrup, Tablet) six different 
media were used. All media including mannitol salt 
agar, MacConkey agar, xylose lysine deoxycholate agar, 
cetrimide agar, Columbia agar and Sabouraud dextrose 
agar were prepared according to the directions given on the 
label of the container and sterilized in an autoclave (USP-
35, 2012; IP, 2007). From syrup, microbial growth was 
observed on Sabouraud dextrose agar, and from tablets, 
microbial growth was observed on mannitol salt agar, 
Maconkey salt agar, xylose lysine deoxycholate agar and 
Sabouraud dextrose agar (Senthilraj, Prasad, Janakiraman, 
2014). The microbial growth from syrup was coded as 
SYRSI2SAB and that from tablets as TABSIV1MAN, 
TABSIV2MAC, TABSIV3XYL and TABSIV4SAB, 
respectively. The isolated cultures were allowed to grow 
overnight in nutrient broth at 37°C for isolation of DNA.
DNA Isolation
The isolate was centrifuged at 5000 rpm, mixed 
with 10 µl Tris–EDTA buffer (pH 8.0), and centrifuged 
again until a pellet was obtained. The Tris–EDTA buffer 
and lysozyme were added to the microbial pellet and 
then incubated at 37 °C for 30 minutes. The cells were 
lysed by the addition of 3 µL of 10% sodium dodecyl 
sulfate and 3 µL of proteinase K solution followed by a 
15-minute incubation at 37 °C. Subsequently, 1 µL of 5 M 
sodium chloride and 80 µL of cetyltrimethylammonium 
bromide were added. The water phase was extracted with 
chloroform:isoamyl alcohol (24:1) (780 µL), and the 
mixture was centrifuged at 10,000 rpm. Isopropanol (0.6 
mL) was added to the supernatant and the mixture was 
again centrifuged at 10,000 rpm for 5 min, after which the 
supernatant was removed. The ethanol washed, air-dried 
pellets were suspended in Tris–EDTA buffer and stored at 
4 °C until they were used. (Nishiguchi et al., 2002; Vural, 
Ozgun, 2011). DNA was extracted using the QIAamp 
Tissue Kit (Loeffler et al., 1996).
16S gene Amplification
PCR for the amplification of the 16S rRNA 
gene was carried out using universal primers 27F 
(5′-AGAGTTTGATCATGGCTCAG-3′) as forward and 
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1492R (5′-GGTTACCTTGTTACGACTT-3′) as reverse 
primer. (Lane, 1991; Turner et al., 1999). Approximately 
10 to 100 ng of template were added to a reaction 
mix containing 20 mM Tris-HCl (pH 8.4), 50 mM 
KCl, 1.5 mM MgCl2, 2 μL of each deoxynucleoside 
triphosphate, 0.4 μM of each primer, and 2.5 U Taq DNA 
polymerase to complete a final volume of 50 μL. The PCR 
conditions were: initial denaturation of 2 min at 94 °C, 
followed by 35 cycles of 1 min at 94 °C, 1.5 min at 55 °C 
and 1 min at 72 °C, and a final extension at 72°C for 3 min. 
The reaction product was visualized on a 1% agarose gel 
under UV light after ethidium bromide staining (Silva et 
al., 2013; Devereux, Wilkinson, 2004). 
16S rRNA gene sequencing and phylogenetic 
analysis
The amplified PCR products of microbial gene 
fragments were purified and sequenced at MACROGEN 
sequencing company, Seoul, Korea using the automated 
sequencer ABI 3100 with Big Dye Terminator Kit v. 3.1. 
Primers 518F (5’CCAGCAGCCGCGGTAATACG3’) and 
800R (5’TACCAGGGTATCTAATCC3’) were used for 
sequencing (Ghyselinck et al., 2013). The sequences thus 
obtained were compared with the NCBI database through 
BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
In this comparison, sequences of type strains most closely 
related to the sequences of the isolates were searched. The 
sequences were aligned with Clustal W, and a phylogenetic 
tree was constructed from the evolutionary distances by 
the neighbor-joining method with the software MEGA 
(Nikunjkumar, 2012; Tamura et al., 2011). 
RESULTS AND DISCUSSION
Isolate-1 from syrup (SYRSI2SAB) had a nucleotide 
sequence of 1425 bp (Fig. 1). NCBI-BLAST search results 
showed the highest sequence similarity with Bacillus 
tequilensis belonging to the family Bacillaceae, and the 
accession number was NR 104919.
Isolates-2, -3, -4 and -5 from tablets (TABSIV1MAN, 
TABSIV2MAC, TABSIV3XYL and TABSIV4SAB) had 
nucleotide sequences of 1600, 1882, 1590 and 1550 bp and 
are shown in Figs. 3, 5, 7 and 9. The NCBI-BLAST search 
results for isolates-2, -3, -4 and-5 had highest sequence 
similarity with the following bacteria, whose accession 
numbers are given in parentheses: B. amyloliqueficians 
(NR116022), B. subtilis (NR112629), Staphylococcus 
haemolyticus (NR036955) and B. amyloliqueficians 
(NR104919). Thus, the BLAST search of Genbank for 
all isolates provided the percentage similarity between 
the microorganism tested and those detected in Genbank 
as shown in Table I.
Furthermore, the neighbor-joining tree based on 
16S rRNA gene sequences was constructed to show the 
relationship between isolate-1 and 12 representative 
species of the family Bacillaceae (Fig. 2). This result 
also confirmed the result of NCBI-BLAST for isolate-1. 
Likewise, for isolates-2, -3, -4 and -5, the neighbor-
joining trees based on 16S rRNA gene sequences were 
constructed to show the relationship between the isolates 
and their representative species of the family Bacillaceae, 
and Staphylococcaceae, as shown in Figs. 4, 6, 8 and 
10. Thus, the above results showed that contaminants 
of non-parenteral pharmaceutical products belonged to 
Bacillus and Staphylococcus species and the names of the 
contaminants are given in Table II.
CONCLUSION 
As discussed earlier, the universal primers 27F and 
1492R produced well-amplified 16S r RNA PCR products 
for all isolates. The nucleotide sequence obtained for all 
isolates was approximately 1500 bp by using the universal 
sequencing primers 518F and 800R (Ghyselinck et al., 
2013) which are sufficient for NCBI-BLAST searches and 
phylogenetic analysis for the identification of unknown 
microorganisms. 
 The time for microbial identification was reduced 
by molecular-based PCR techniques when compared 
to conventional methods of detection. But PCR detects 
only the fixed target microorganism and it will not detect 
TABLE I - Percentage similarity of tested strains against representative species in BLAST search
S. No. Test strains Representative species Percentage similarity (BLAST)
1. SYRSI2SAB Bacillus tequilensis (NR 140919) 99%
2. TABSIV1MAN Bacillus amyloliquefaciens (NR 116022) 99%
3. TABSIV2MAC Bacilus subtilis (NR 112629) 99%
4. TABSIV3XYL Sthaphylicoccus haemolyticus (NR 036955) 99%
5. TABSVI4SAB Bacillus amyloliquefaciens (NR 112685) 99%
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FIGURE 1 - The 16S rRNA sequence generated for isolate-1 
had 1425 bases. 
FIGURE 2 - Neighbor-joining tree based on 16S rRNA (1425) 
sequences showing the relationship between unknown isolate 
SYRSI1SAB and other closely related species of the genus 
Bacillus.
FIGURE 3 - The 16S rRNA sequence generated for isolate-2 
had 1600 bases.
FIGURE 4 - Neighbor-joining tree based on 16S rRNA (1600) 
sequences showing the relationship between unknown isolate 
TABSIV1MAN and other closely related species of the genus 
Bacillus.
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FIGURE 5 - The 16S rRNA sequence generated for isolate-3 
had 1822 bases. 
FIGURE 6 - Neighbor-joining tree based on 16S rRNA (1822) 
sequences showing the relationship between unknown isolate 
TABSIV2MAC and other closely related species of the genus 
Bacillus.
FIGURE 7 - The 16S rRNA sequence generated for isolate-4 
had 1590 bases. 
FIGURE 8 - Neighbor-joining tree based on 16S rRNA (1590) 
sequences showing the relationship between unknown isolate 
TABSIV3XYL and other closely related species of the genus 
Staphylococcus.
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TABLE II - Microbial isolates from non-parenterals identified by 
16S rRNA sequence 
Isolates Fprmulation
Microbial isolate 
(contaminant) identified by 
16S rRNA sequence
Isolates-1 Syrup Bacillus tequilensis
Isolates-2 Tablets Bacillus amyloliquefaciens
Isolates-3 Tablets Bacilus subtilis
Isolates-4 Tablets Sthaphylococcus haemolyticus
Isolates-5 Tablets Bacillus amyloliquefaciens
FIGURE 9 - The 16S rRNA sequence generated for isolate-5 
had 1550 bases. 
FIGURE 10 - Neighbor-joining tree based on 16S rRNA (1550) 
sequences showing the relationship between unknown isolate 
TABSIV4SAB) and other closely related species of the genus 
Bacillus.
other microorganisms of interest (Jimenez, Ignar, 2000). 
Although it takes 6 to 7 hours more than PCR methods, 
16S rRNA sequence-based analysis gives very accurate 
information about all microbial contaminants and also 
confirms the presence of any other pathogens by virtue 
of its specificity (Rompre et al., 2002; Gee et al., 2003; 
Rhoads et al., 2012). As discussed earlier about sequence 
analysis, this study also confirmed 16S rRNA as the 
most ideal and suitable method for the identification of 
microbial contaminants in non-parenteral products. Hence, 
microbial quality control for non-parenteral products by 
16S rRNA sequence-based identification can be employed 
on a routine basis as a pharmacopoeial protocol to ensure 
simplicity, reliability and rapidity.
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